Prolactin and DNA damage trigger an anti-breast cancer cell immune response
These results demonstrate that combined breast cancer cell DNA damage and PRL exposure results in the anti-tumor cell activity of asialo-GM1-positive immune cells.
Authors
- Nayantara Govindrajan
- Ödül Karayazi Atıcı
- Carrie S. Shemanko (ORCID: https://orcid.org/0000-0002-5260-6210)
- Constance A. M. Finney (ORCID: https://orcid.org/0000-0002-8459-8462)
- Isbel Lopetegui-González (ORCID: https://orcid.org/0000-0003-1399-7703)
Institutions
- University of Calgary (CA)
- Institute of Cancer Research (CA)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-09-23
- DOI
- https://doi.org/10.3389/fendo.2025.1586062
- Primary Topic
- Growth Hormone and Insulin-like Growth Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Alberta Cancer Foundation
- Natural Sciences and Engineering Research Council of Canada